PBPH vs. FTXH
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Health & Biotech Equities funds - PBPH tracks the BITA Global Pharma and Biotech Select Index while FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Their correlation of 0.91 suggests significant overlap in exposure. PBPH charges 0.13%/yr vs 0.60%/yr for FTXH.
Performance
PBPH vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBPH achieves a -1.13% return, which is significantly lower than FTXH's 5.00% return.
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
FTXH
- 1D
- 1.69%
- 1M
- 1.65%
- YTD
- 5.00%
- 6M
- 6.02%
- 1Y
- 36.24%
- 3Y*
- 11.48%
- 5Y*
- 7.80%
- 10Y*
- —
PBPH vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 5.00% | -0.21% |
Correlation
The correlation between PBPH and FTXH is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.91 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBPH vs. FTXH — Risk / Return Rank
PBPH
FTXH
PBPH vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| PBPH | FTXH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.14 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.48 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.38 | -0.42 |
Drawdowns
PBPH vs. FTXH - Drawdown Comparison
The maximum PBPH drawdown since its inception was -11.10%, smaller than the maximum FTXH drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for PBPH and FTXH.
Loading charts...
Drawdown Indicators
| PBPH | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.10% | -32.11% | +21.01% |
Max Drawdown (1Y)Largest decline over 1 year | — | -7.47% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -19.51% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.51% | — |
Current DrawdownCurrent decline from peak | -8.69% | -2.88% | -5.81% |
Average DrawdownAverage peak-to-trough decline | -4.23% | -5.84% | +1.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.58% | — |
Volatility
PBPH vs. FTXH - Volatility Comparison
Loading charts...
Volatility by Period
| PBPH | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.83% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 11.73% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 16.78% | 16.98% | -0.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.78% | 16.31% | +0.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.78% | 18.41% | -1.63% |
PBPH vs. FTXH - Expense Ratio Comparison
PBPH has a 0.13% expense ratio, which is lower than FTXH's 0.60% expense ratio.
Dividends
PBPH vs. FTXH - Dividend Comparison
PBPH's dividend yield for the trailing twelve months is around 0.09%, less than FTXH's 1.22% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.22% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
With a correlation of 0.91, PBPH and FTXH move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.60% for FTXH.
FTXH has the higher dividend yield at 1.22%, compared with 0.09% for PBPH.
PBPH tracks BITA Global Pharma and Biotech Select Index, while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: Portfolio Building Block and First Trust. Their fees differ too: 0.13% for PBPH and 0.60% for FTXH.
Find the right allocation for PBPH and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer